$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Prevention and treatment of pain using antibodies to sphingosine-1-phosphate 원문보기

IPC분류정보
국가/구분 United States(US) Patent 등록
국제특허분류(IPC7판)
  • A61K-039/395
  • C07K-016/44
  • A61K-039/00
출원번호 US-0246704 (2011-09-27)
등록번호 US-8871202 (2014-10-28)
발명자 / 주소
  • Sabbadini, Roger A.
출원인 / 주소
  • Lpath, Inc.
대리인 / 주소
    Acuity Law Group, P.C.
인용정보 피인용 횟수 : 1  인용 특허 : 101

초록

The present invention relates to use of anti-S1P agents, for example, humanized monoclonal antibodies, for prevention and/or treatment of pain, including neuropathic pain, hyperalgesia, allodynia, and chemotherapy-induced pain.

대표청구항

1. A method of reducing, or reducing the development of, neuropathic pain, allodynia or hyperalgesia in a human subject, comprising administering to a human subject having or believed to be at risk of having pain an antibody or fragment thereof that binds and neutralizes sphingosine-1-phosphate (S1P

이 특허에 인용된 특허 (101)

  1. Winter, Gregory Paul, Altered antibodies.
  2. Shayman James A. ; Radin Norman S., Amino ceramide-like compounds and therapeutic methods of use.
  3. Winter Gregory P. (Cambridge GB3) Duncan Alexander R. (Wimbledon GB3) Burton Dennis R. (Sheffield GB3), Antibodies with altered effector functions.
  4. Man Sung Co ; David A. Scheinberg ; Cary L. Queen, Antibodies with increased binding affinity.
  5. Philip E. Thorpe ; Rolf A. Brekken, Antibody conjugate compositions for selectively inhibiting VEGF.
  6. Weiner George ; Gingrich Roger ; Link Brian K. ; Tso J. Yun, Bispecific antibody effective to treat B-cell lymphoma and cell line.
  7. Tso J. Yun ; Kostelny Sheri A. ; Cole Michael S., Bispecific antibody heterodimers.
  8. Iwashita Yuji (Kawasaki JPX) Ajisaka Katsumi (Yokohama JPX), Blood substitute containing modified hemoglobin.
  9. Baker Joffre (El Granada CA) Chien Kenneth (La Jolla CA) King Kathleen (Pacifica CA) Pennice Diane (Burlingame CA) Wood William (San Mateo CA), Cardiac hypertrophy factor and uses therefor.
  10. Darfler Frederick J. (Derwood MD), Cell culture medium with antioxidant.
  11. Seidman Jonathan G. (Milton MA) Jakobovits Aya (Menlo Park CA), Cells homozygous for disrupted target loci.
  12. Nakagawa Yasushi (Kawanishi JPX) Ito Takashi (Osaka JPX), Chemically modified protein with polyethyleneglycol.
  13. Chun Jerold J. M. ; Hecht Jonathan H., Cloned lysophosphatidic acid receptors.
  14. Sabbadini, Roger, Compositions and methods for early detection of heart disease.
  15. Sabbadini,Roger A., Compositions and methods for the treatment and prevention of cancer, angiogenesis, and inflammation.
  16. Sabbadini, Roger A., Compositions and methods for the treatment and prevention of cardiovascular diseases and disorders, and for identifying agents therapeutic therefor.
  17. Sabbadini, Roger A., Compositions and methods for the treatment and prevention of cardiovascular diseases and disorders, and for identifying agents therapeutic therefor.
  18. Carson Dennis A. ; Cottam Howard, Compounds for inhibition of ceramide-mediated signal transduction.
  19. Mitra Gautam (Kensington CA), Covalently attached complex of alpha-1-proteinase inhibitor with a water soluble polymer.
  20. Igarashi Yasuyuki (Seattle WA) Ahmad Mahammad N. (Seattle WA) Okoshi Hirofumi (Seattle WA) Hakomori Sen-Itiroh (Mercer Island WA), Effect of N,N,N,-trimethylsphingosine on protein kinase C activity melanoma cell growth in vitro; metastatic potential i.
  21. Handa Kazuko (Seattle WA) Igarashi Yasuyuki (Seattle WA) Ahmad Mahammad N. (Seattle WA) Hakomori Sen-Itiroh (Mercer Island WA), Effect of N,N,N-trimethylsphingosine on protein kinase-C activity, melanoma cell growth in vitro, metastatic potential i.
  22. Kimura Satoshi (Seattle WA) Igarashi Yasuyuki (Seattle WA) Hakomori Sen-itiroh (Seattle WA) Ahmad Mohammad N. (Seattle WA) Okoshi Hirofumi (Seattle WA) Handa Kazuko (Seattle WA), Effect of N,N,N-trimethylsphingosine on protein kinase-C activity; melanoma cell growth in vitro; metastatic potential i.
  23. Lerner Richard (La Jolla CA) Janda Kim (San Diego CA) Brenner Sydney (Cambridge GB2), Encoded combinatorial chemical libraries.
  24. Amtmann Eberhard,DEX ; Frank Norbert,DEX ; Sauer Gerhard,DEX ; Schilling Gerhard,DEX, Guanidine derivatives, methods of preparing them and their use as drugs.
  25. Iwasaki Keiji (Kawasaki JPX) Iwashita Yuji (Kawasaki JPX) Okami Taketoshi (Yokohama JPX), Hemoglobin combined with a poly(alkylene oxide).
  26. Boguslaski Robert C. (Elkhart IN) Carrico Robert J. (Bremen IN) Christner James E. (Ann Arbor MI), Heterogenous specific binding assay employing a cycling reactant as label.
  27. Tsui Ping, Human EDG3sb gene.
  28. Barbas, III,Carlos F.; Rader,Christoph, Humanization of murine antibody.
  29. Goldstein,Neil I.; Giorgio,Nicholas A.; Jones,Steven Tarran; Saldanha,Jose William, Humanized anti-EGF receptor monoclonal antibody.
  30. Lin Augustine Y., Humanized antibodies and uses thereof.
  31. Co Man Sung ; Tso J. Yun, Humanized antibodies reactive with GPIIB/IIIA.
  32. Co Man Sung, Humanized antibodies reactive with L-selectin.
  33. Vasquez Maximiliano ; Landolfi Nicholas F. ; Tsurushita Naoya ; Queen Cary L., Humanized antibodies to .gamma.-interferon.
  34. Philip R. Tempest GB; William J. Harris GB; Frank J. Carr GB, Humanized antibodies to Fc receptors for immunoglobulin G on human mononuclear phagocytes.
  35. Wayne A. Marasco ; Joyce Lavecchio ; Abner Mhashilkar ; Urban Ramstedt ; David Ring ; Bridget Eberhardt ; Julie Porter-Brooks, Humanized antibody and uses thereof.
  36. Queen Cary L. (Los Altos CA) Co Man Sung (Cupertino CA) Schneider William P. (Mountain View CA) Landolfi Nicholas F. (Milpitas CA) Coelingh Kathleen L. (San Francisco CA) Selick Harold E. (Belmont CA, Humanized immunoglobulins.
  37. Queen Cary L. (Los Altos CA) Selick Harold E. (Belmont CA), Humanized immunoglobulins.
  38. Queen Cary L. (Los Altos CA) Selick Harold E. (Belmont CA), Humanized immunoglobulins.
  39. Queen Cary L. ; Selick Harold E., Humanized immunoglobulins and methods of making the same.
  40. Smith David S. (London GB2), Immunoassay for gentamicin.
  41. David Gary S. (La Jolla CA) Greene Howard E. (Carlsbad CA), Immunometric assays using monoclonal antibodies.
  42. Goroff Diana K. (Chevy Chase MD), In-vitro method for producing antigen-specific human monoclonal antibodies.
  43. Co Man Sung ; Scheinberg David A. ; Queen Cary L., Increasing antibody affinity by altering glycosylation in the immunoglobulin variable region.
  44. Bell Robert M. (Durham NC) Loomis Carson (Durham NC) Hannun Yusuf (Durham NC), Inhibition of protein kinase C by long-chain bases.
  45. Bell Robert M. (Durham NC) Loomis Carson (Durham NC) Hannun Yusuf (Durham NC), Inhibition of protein kinase C by long-chain bases.
  46. Hannun Yusuf A. ; Bielawska Alicja ; McKay Charles, Inhibitors of ceramidase.
  47. Sabbadini, Roger A., Kits for early detection of heart disease.
  48. Ryan, Patrick J.; Davis, Michael A.; Melchior, Donald L., Liposomes containing modified cholesterol for organ targeting.
  49. Woodle Martin C. (Menlo Park CA) Martin Francis J. (San Francisco CA) Yau-Young Annie (Los Altos CA) Redemann Carl T. (Walnut Creek CA), Liposomes with enhanced circulation time.
  50. Litman David J. (Palo Alto CA) Harel Zvi (Stanford CA) Ullman Edwin F. (Atherton CA), Macromolecular environment control in specific receptor assays.
  51. Munroe Donald G.,CAX ; Gupta Ashwani K.,CAX ; Vyas Tejal B.,CAX ; Chun Jerold J. M., Mammalian EDG-5 receptor homologs.
  52. Patel Pramathesh S. (Ringoes NJ) Shu Yue-Zhong (Cheshire CT), Manumycin compounds.
  53. Zeeck Axel (Gttingen DEX) Thiericke Ralf (Gttingen DEX) Zhner Hans (Tbingen DEX) Dickneite Gerhard (Marburg DEX) Sedlacek Hans H. (Marburg DEX), Manumycin derivatives and the use thereof.
  54. Mather Jennie P. (Millbrae CA) Tsao Mary C. (Burlingame CA), Method for culturing Chinese hamster ovary cells to improve production of recombinant proteins.
  55. Igarashi Yasuyuki (Seattle WA) Ruan Fugiang (Seattle WA) Sadahira Yoshito (Seattle WA) Kawa Shigeyuki (Seattle WA) Hakomori Sen-itiroh (Seattle WA), Method for inhibition of cell motility by sphingosine-1-phosphate and derivatives.
  56. Igarashi Yasuyuki (Seattle WA) Ruan Fuqiang (Seattle WA) Sadahira Yoshito (Seattle WA) Kawa Shigeyuki (Seattle WA) Hakomori Sen-itiroh (Seattle WA), Method for inhibition of cell motility by sphingosine-1-phosphate, its derivatives and mimetics and method of synthesizi.
  57. Carter Paul J. ; Presta Leonard G. ; Ridgway John B., Method for making heteromultimeric polypeptides.
  58. Carter, Paul J.; Presta, Leonard G., Method for making humanized antibodies.
  59. Paul J. Carter ; Leonard G. Presta, Method for making humanized antibodies.
  60. Tabas Ira ; Schissel Scott L. ; Williams Kevin Jon, Method for treating a subject suffering from a condition associated with an extracellular zinc sphingomyelinase.
  61. Tabas, Ira; Schissel, Scott L.; Williams, Kevin Jon, Method for treating a subject suffering from conditions associated with an extracellular zinc sphingomyelinase.
  62. Woodcock Elizabeth Anne,AUX ; Anderson Karen Elizabeth,AUX ; Dart Anthony Michael,AUX ; Du Xiao-Jun,AUX, Method for treating cardiac dysfunction and pharmaceutical compositions useful therefor.
  63. Hannun Yusuf A. (Chapel Hill NC) Bielawska Alicja (Apex NC), Method of inducing cellular differentiations and altering cell phenotype using ceramide analogs.
  64. Igarashi Yasuyuki (Seattle WA) Ahmad Mahammad N. (Seattle WA) Okoshi Hirofumi (Seattle WA) Hakomori Sen-Itiroh (Mercer Island WA), Method of preparing N,N,N-trimethylsphingosine.
  65. Light Susan ; Queen Cary, Method of preventing acute rejection following solid organ transplantation.
  66. Borrebaeck Carl (Lund SEX) Danielsson Lena (Lund SEX) Moller Susanna (Lund SEX), Method of producing human monoclonal antibodies and kit therefor.
  67. Sabbadini Roger A., Methods for early detection of heart disease.
  68. MacLennan Alexander J. (7811 NW. 35th Pl. Gainesville FL 32606), Molecular cloning and expression of G-protein coupled receptors.
  69. Chang Chung Nan ; Landolfi Nicholas F. ; Martin Ulrich,DEX, Monoclonal antibodies specific for the platelet derived growth factor .beta. receptor and methods of use thereof.
  70. Boss Michael A. (Slough GBX) Kenten John H. (High Wycombe GBX) Emtage John S. (High Wycombe GBX) Wood Clive R. (Near Fordingbridge GBX), Multichain polypeptides or proteins and processes for their production.
  71. Tso J. Yun ; Cole Michael S. ; Anasetti Claudio, Mutated nonactivating IgG2 domains and anti CD3 antibodies incorporating the same.
  72. Davis Frank F. (19 Farmingdale Rd. East Brunswick NJ 08816) Van Es Theodorus (313 Overbrook Rd. Piscataway NJ 08854) Palczuk Nicholas C. (45 W. Franklin St. Bound Brook NJ 08805), Non-immunogenic polypeptides.
  73. Shimizu Kimihiro (Yoshikawa JPX) Nakahara Tsuguji (Tokyo JPX) Kinoshita Taketoshi (Koshigaya JPX) Takatsuka Jun (Kawasaki JPX) Igarashi Michiko (Musashino JPX), Plasminogen activator derivatives.
  74. Duckworth David Malcolm,GBX ; Godden Robert James,GBX ; Testa Tania Tamson,GBX, Polynucleotides encoding human sphingosine Lyase.
  75. Queen Cary L. (Los Altos CA) Schneider William P. (Mountain View CA) Selick Harold E. (Belmont CA), Polynucleotides encoding improved humanized immunoglobulins.
  76. Presta Leonard G. ; Snedecor Bradley R., Polypeptides altered to contain an epitope from the Fc region of an IgG molecule for increased half-life.
  77. Holton Robert A. (Tallahassee FL), Preparation of substituted isoserine esters using b 상세보기
  • Surani Azim M. (Cambridge GB3) Neuberger Michael S. (Cambridge GB3) Bruggemann Marianne (Cambridge GB3), Production of antibodies from transgenic animals.
  • Hoogenboom Hendricus R. J. M. (Cambridge GBX) Baier Michael (Frankfurt DEX) Jespers Laurent S. A. T. (Tervuren BEX) Winter Gregory P. (Cambridge GBX), Production of chimeric antibodies - a combinatorial approach.
  • Fell H. Perry (Redmond WA) Folger Bruce Kim R. (Seattle WA), Production of chimeric antibodies by homologous recombination.
  • Cleveland William L. (New York NY) Erlanger Bernard F. (Whitestone NY), Protein-free culture medium.
  • Chatterjee Subroto, Recombinant N-SMases and nucleic acids encoding same.
  • Winter Gregory P. (Cambridge GBX), Recombinant altered antibodies and methods of making altered antibodies.
  • Cabilly Shmuel (Monrovia CA) Heyneker Herbert L. (Burlingame CA) Holmes William E. (Pacifica CA) Riggs Arthur D. (La Verne CA) Wetzel Ronald B. (San Francisco CA), Recombinant immunoglobin preparations.
  • Weng Litai (Mountain View CA) Gibbons Iam (Menlo Park CA), Reducing interference in ligand-receptor binding assays.
  • Lazes Richard J. (804 First Ave. Harvey LA 70058), Rotating containment and repelling boom and method for confining a material floatable on a liquid surface.
  • Gamble, Jennifer; Vadas, Mathew; Xia, Pu; Barter, Phillip; Rye, Kerry-Anne; Wattenberg, Brian; Pitson, Stuart, Screening method for an agent having an effect on a sphingosine kinase signaling pathway.
  • Cartaya Oscar A. (125 Pleasant St. ; Apt. #401 Brookline MA 02146), Serum-free cell culture media.
  • Baker, Paul E., Serum-free cell culture medium and process for making same.
  • Kumar Sudhir (18901 Springfield Flossmoor IL 60422), Serum-free, synthetic, completely chemically defined tissue culture media.
  • Liotta, Dennis C.; Merrill, Jr., Alfred H.; Keane, Thomas E.; Bhalla, Kapil N.; Schmelz, Eva M, Sphingolipid derivatives and their methods of use.
  • Igarashi Yasuyuki (Seattle WA) Ruan Fuqiang (Seattle WA) Sadahira Yoshito (Seattle WA) Kawa Shigeyuki (Seattle WA) Hakomori Sen-itiroh (Seattle WA), Sphingosine-1-phosphate essentially free of L-threo isomer.
  • Julie D. Saba ; Jianhui Zhou, Sphingosine-1-phosphate lyase polypeptides, polynucleotides and modulating agents and methods of use therefor.
  • Park Yong S. (Seattle WA) Igarashi Yasuyuki (Seattle WA) Hakomori Sen-itiroh (Seattle WA), Sphingosine-1-phosphate/trimethylsphingosine composition.
  • Wachter Michael P. ; Lalan Praful, Substituted amino acids as neutral sphingomyelinase inhibitors.
  • Hines, Jacqueline; Carpenter, Charles; Solie, Leland P., Surface-acoustic-wave pressure sensor and associated methods.
  • Regen Steven L. (Milwaukee WI), Synthetic phosphatidyl cholines useful in forming liposomes.
  • Segal David M. (Rockville MD) Perez Pilar (Bethesda MD), Target specific cross-linked heteroantibodies.
  • Krimpenfort Paulus J. A. (Amsterdam NLX) Berns Antonius J. M. (Spaarndam NLX), Transgenic mice depleted in a mature lymphocytic cell-type.
  • Barry J. Maurer ; Myles Cabot ; C. Patrick Reynolds, Treatment of hyperproliferative disorders.
  • Marangos Paul J. (Encinitas CA), Use of aminoglycosides to protect against excitotoxic neuron damage.
  • 이 특허를 인용한 특허 (1)

    1. Lang, Timothy Joel; Collings, Patrick X.; Graham, Douglas K., Flow control methods and devices.
    섹션별 컨텐츠 바로가기

    AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

    AI-Helper 아이콘
    AI-Helper
    안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
    ※ AI-Helper는 부적절한 답변을 할 수 있습니다.

    선택된 텍스트

    맨위로